Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group
Titel:
Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group
Auteur:
Schmiegel, W. Reinacher-Schick, A. Arnold, D. Kubicka, S. Freier, W. Dietrich, G. Geißler, M. Hegewisch-Becker, S. Tannapfel, A. Pohl, M. Hinke, A. Schmoll, H.J. Graeven, U.